Asarfi Hospital Ltd.

78.20 +0.71 ▲0.9%

25 April 2024, 04:01:00 PM
Volume: 7,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.asarfi.in
Market Cap 153.88 Cr.
Enterprise Value(EV) 185.89 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.07 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 19.20 Trailing Twelve Months Ending 2023-03
Industry PE 67.10 Trailing Twelve Months Ending 2023-03
Book Value / Share 34.95 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.24 Calculated using Price: 78.20
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.97 Cr. 19,677,300 Shares
FaceValue 10
About Asarfi Hospital Ltd.
The company is an integrated healthcare service provider, committed to deliver valued healthcare services to its patients that includes prevention, treatment and proper rehabilitation.

Asarfi Hospital Ltd. Delivery

Delivered Qty
Traded Qty

Asarfi Hospital Ltd. Performance

1 Day
+0.92%
1 Week
-1.39%
1 Month
+26.56%
3 Month
-22.19%
6 Month
-22.19%
1 Year
2 Year
5 Year
10 Year

Asarfi Hospital Ltd. Fundamental Ratios

4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 19.66 23.36 28.99 24.87
Return on Capital Employed (%) 21.8 25.21 28.88 26.21
Return on Assets (%) 9.51 10.89 11.46 10.27

Asarfi Hospital Ltd. Balance Sheet

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 17 23 42 68
Non Curr. Liab. 6 12 25 32 44
Curr. Liab. 8 9 15 20 44
Minority Int.
Equity & Liab. 28 37 63 93 156
Non Curr. Assets 19 28 41 57 95
Curr. Assets 9 10 22 37 61
Misc. Exp. not W/O
Total Assets 28 37 63 93 156

Asarfi Hospital Ltd. Profit and Loss

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 43 54 65 69
Other Income 0 0 1 2
Total Income 43 54 66 71
Total Expenditure -37 -46 -54 -55
PBIDT 7 8 12 16
Interest -1 -1 -1 -1
Depreciation -2 -3 -3 -4
Taxation -1 -1 -2 -3
Exceptional Items
PAT 3 4 6 8
Adjusted EPS 4 5 8 6

Asarfi Hospital Ltd. Cash Flow

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2 10 9 -2
Cash Fr. Inv. -5 -16 -23 -14
Cash Fr. Finan. 2 6 14 17
Net Change 0 0 1
Cash & Cash Eqvt 0 0 0 1

Asarfi Hospital Ltd. Shareholding Pattern

2 Qtrs 2023-09 (%) 2024-03 (%)
Promoter 61.17 61.17
Public 38.83 38.83
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00
No. of Shareholders (in Lacs)

Asarfi Hospital Ltd. Announcements

Tue, 16 Apr 2024
Closure of Trading Window
Intimation of closure of Trading window under regulation SEBI PIT Regulation 2015.
Tue, 16 Apr 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance
Declaration of Non -Applicability of Secretarial Compliance report under regulation 24 A (2) of SEBI LODR.
Mon, 15 Apr 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.
WE WISH TO INFORM YOU FOR THE HALF YEAR ENDED MARCH 31st 2024 THERE WAS NO MATERIAL DEVIATION IN THE USE OF PROCEEDS OF ISSUE.

Asarfi Hospital Ltd. Technical Scans

Wed, 24 Apr 2024
Opening at Low Opening at Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Asarfi Hospital Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Asarfi Hospital Ltd. FAQ's

What is Asarfi Hospital Ltd. share price?

Can I buy Asarfi Hospital Ltd. shares now?

What is the Market Cap of Asarfi Hospital Ltd.?

What are the key metrics to analyse Asarfi Hospital Ltd.?

What is the 52 Week High and Low of Asarfi Hospital Ltd.?

What is the trend of Asarfi Hospital Ltd. share price?